Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - PROGENICS PHARMACEUTICALS INC | Financial_Report.xls |
| EX-12.1 - EXHIBIT 12.1 RATIO - PROGENICS PHARMACEUTICALS INC | ex12_112312011.htm |
| EX-32.1 - EXHIBIT 32.1 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex32_112312011.htm |
| EX-31.1 - EXHIBIT 31.1 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex31_112312011.htm |
| EX-31.2 - EXHIBIT 31.2 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex31_212312011.htm |
| EX-32.2 - EXHIBIT 32.2 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex32_212312011.htm |
| 10-K - PROGENICS FORM 10-K DECEMBER 31, 2011 - PROGENICS PHARMACEUTICALS INC | form10_k12312011.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-176244) and Form S-8 (Nos. 333-52277, 333-120508, 333-124910, 333-143670, 333-160389, 333-160392, 333-168124, 333-176204) of Progenics Pharmaceuticals, Inc. of our report dated March 15, 2012 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
New York, New York
March 15, 2012